{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:18:06Z","timestamp":1774538286191,"version":"3.50.1"},"reference-count":139,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"unspecified","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Rosa og Asta Jensens Fond","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Vascular Research Unit, Regional Hospital Viborg","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Department of Cardiology Research","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Health Research Foundation of Central Denmark Region","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,11]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Atherosclerotic cardiovascular disease (ASCVD) is the main cause of death globally, but is by and large a preventable disease. We wished to identify, categorise and map adherence measurements of preventative treatment strategies in patients with ASCVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and data sources<\/jats:title>\n                    <jats:p>We conducted a scoping review according to the Joanna Briggs Institue (JBI) methodology and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews guidelines. A comprehensive search was performed in PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science and EMBASE (Elsevier Biomedical Research database). The search was conducted in May 2023 and updated in November 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria<\/jats:title>\n                    <jats:p>Observational studies pertaining to major types of ASCVD and related preventive treatment with reported adherence measures in adults over the age of 18 were included in this review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data extraction and synthesis<\/jats:title>\n                    <jats:p>Title and abstract and subsequent full-text review were performed by two independent reviewers in duplicate. We presented data from the included 108 studies and synthesised the results in an overview of the most commonly used adherence measurements according to ASCVD category.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 108 records met the inclusion criteria. ASCVD populations included ranged in age from 40 to 91 years, with a male predominance (85%). Medication adherence was mostly reported by the proportion of patients taking their medication (15 studies, 14%) or the proportion of days covered (12 studies, 11%). Among the 108 included studies, 67 (62%) reported on medication adherence, 65 (60%) on smoking cessation, 39 (36%) on low-density lipoprotein cholesterol guideline adherence, 39 (36%) on exercise, 17 (16%) on diet and 11 (10%) on alcohol abstinence. Unspecified patient-reported outcome measures (PROMs) were the most used method for assessing medication adherence, reported in 15 studies (22%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Medication adherence was the most frequently assessed domain in secondary prevention of ASCVD, with unspecified PROMs being the most applied measurement approach. Lack of a gold standard combined with inconsistent adherence measures across studies of ASCVD continues to pose a significant challenge for evaluating treatment quality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-109666","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:20:55Z","timestamp":1774534855000},"page":"e109666","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Measuring patient adherence in secondary prevention of atherosclerotic cardiovascular disease: a scoping review"],"prefix":"10.1136","volume":"16","author":[{"given":"Malene","family":"Glud","sequence":"first","affiliation":[{"name":"Vascular Research Unit, Department of Vascular Surgery, Hospitalsenhed Midt, Viborg, Denmark"},{"name":"Aarhus University Department of Clinical Medicine, Aarhus, Central Denmark Region, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6526-8663","authenticated-orcid":false,"given":"Nikolaj Thure","family":"Krarup","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospitalsenhed Midt, Viborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten B","family":"Juhl","sequence":"additional","affiliation":[{"name":"Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Region Syddanmark, Denmark"},{"name":"Department of Physiotherapy and Occupational Therapy, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Stenholt","sequence":"additional","affiliation":[{"name":"Medical Library, Hospitalsenhed Midt, Viborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane Kjemtrup","family":"Andersen","sequence":"additional","affiliation":[{"name":"Medical Library, Hospitalsenhed Midt, Viborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Kongsgaard Nielsen","sequence":"additional","affiliation":[{"name":"Quality of Life Research Center, Department of Hematology, Odense University Hospital, Odense, Denmark"},{"name":"Department of Clinical Research, University of Southern Denmark, Odense, Region Syddanmark, Denmark"},{"name":"Section of Hematology, Regionshospitalet Godstrup, Herning, Central Denmark Region, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Dahl","sequence":"additional","affiliation":[{"name":"Vascular Research Unit, Department of Vascular Surgery, Hospitalsenhed Midt, Viborg, Denmark"},{"name":"Aarhus University Department of Clinical Medicine, Aarhus, Central Denmark Region, Denmark"},{"name":"Department of Clinical Research, Research Unit of Cardiac, Thoracic and Vascular Surgery, University of Southern Denmark Faculty of Health Sciences, Odense, Region Syddanmark, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"2026032607201885000_16.3.e109666.1","unstructured":"World Health Organization . Top 10 causes of death. 2020. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death"},{"key":"2026032607201885000_16.3.e109666.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1201534"},{"key":"2026032607201885000_16.3.e109666.3","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-316266"},{"key":"2026032607201885000_16.3.e109666.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaa047"},{"key":"2026032607201885000_16.3.e109666.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"2026032607201885000_16.3.e109666.6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/eurjpc\/zwab115","article-title":"Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys","volume":"29","author":"De Bacquer","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2026032607201885000_16.3.e109666.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2010.03.005"},{"key":"2026032607201885000_16.3.e109666.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-085056","article-title":"Medication adherence of patients with peripheral arterial disease to antithrombotic therapy: a systematic review","volume":"15","author":"Wegerif","year":"2025","journal-title":"BMJ Open"},{"key":"2026032607201885000_16.3.e109666.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.02.006"},{"key":"2026032607201885000_16.3.e109666.10","doi-asserted-by":"crossref","first-page":"103383","DOI":"10.1016\/j.ijnurstu.2019.06.014","article-title":"Cultural factors influencing self-care by persons with cardiovascular disease: An integrative review","volume":"116","author":"Osokpo","year":"2021","journal-title":"Int J Nurs Stud"},{"key":"2026032607201885000_16.3.e109666.11","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13101087","article-title":"Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health","volume":"13","author":"Venditti","year":"2023","journal-title":"Metabolites"},{"key":"2026032607201885000_16.3.e109666.12","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14782"},{"key":"2026032607201885000_16.3.e109666.13","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-023-02340-z","article-title":"Quality of measurement properties of medication adherence instruments in cardiovascular diseases and type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Oliveira","year":"2023","journal-title":"Syst Rev"},{"key":"2026032607201885000_16.3.e109666.14","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/217047","article-title":"Medication Adherence Measures: An Overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed Res Int"},{"key":"2026032607201885000_16.3.e109666.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n1493","article-title":"Medication adherence in cardiovascular medicine","volume":"374","author":"Simon","year":"2021","journal-title":"BMJ"},{"key":"2026032607201885000_16.3.e109666.16","doi-asserted-by":"crossref","DOI":"10.2196\/18150","article-title":"The Need to Develop Standard Measures of Patient Adherence for Big Data: Viewpoint","volume":"22","author":"Kardas","year":"2020","journal-title":"J Med Internet Res"},{"key":"2026032607201885000_16.3.e109666.17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10741-017-9656-x","article-title":"In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review","volume":"23","author":"Krueger","year":"2018","journal-title":"Heart Fail Rev"},{"key":"2026032607201885000_16.3.e109666.18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab484"},{"key":"2026032607201885000_16.3.e109666.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"2026032607201885000_16.3.e109666.20","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2026032607201885000_16.3.e109666.21","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000277"},{"key":"2026032607201885000_16.3.e109666.22","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwad038"},{"key":"2026032607201885000_16.3.e109666.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12912-023-01329-2","article-title":"Illness perception, health literacy, self-efficacy, adherence and quality of life in patients with intermittent claudication - a longitudinal cohort study","volume":"22","author":"Striberger","year":"2023","journal-title":"BMC Nurs"},{"key":"2026032607201885000_16.3.e109666.24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/ehjqcco\/qcaa023","article-title":"Statin dose titration patterns and subsequent major cardiovascular events in very high-risk patients: estimates from Swedish population-based registry data","volume":"6","author":"Banefelt","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026032607201885000_16.3.e109666.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.005"},{"key":"2026032607201885000_16.3.e109666.26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/VHRM.S76651","article-title":"Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease","volume":"11","author":"Chen","year":"2015","journal-title":"Vasc Health Risk Manag"},{"key":"2026032607201885000_16.3.e109666.27","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-019-1032-4","article-title":"Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"2026032607201885000_16.3.e109666.28","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s12325-022-02384-y","article-title":"Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain","volume":"40","author":"Cosin-Sales","year":"2023","journal-title":"Adv Ther"},{"key":"2026032607201885000_16.3.e109666.29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019331","article-title":"Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease","volume":"10","author":"Dayoub","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026032607201885000_16.3.e109666.30","first-page":"556","article-title":"Long-Term Mortality After Invasive Angiography and Endovascular Revascularization in Patients With PAD Having Chronic Kidney Disease","volume":"67","author":"Gebauer","year":"2016","journal-title":"Angiol Open Access"},{"key":"2026032607201885000_16.3.e109666.31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.36469\/001c.28934","article-title":"Secondary Prevention Using Cholesterol-Lowering Medications in Patients with Prior Atherosclerotic Cardiovascular Disease Events: A Retrospective Cohort Analysis","volume":"9","author":"Han","year":"2022","journal-title":"J Health Econ Outcomes Res"},{"key":"2026032607201885000_16.3.e109666.32","first-page":"434","article-title":"Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use","volume":"9","author":"Huang","year":"2016","journal-title":"Am Health Drug Benef"},{"key":"2026032607201885000_16.3.e109666.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2013.04.009"},{"key":"2026032607201885000_16.3.e109666.34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.041974"},{"key":"2026032607201885000_16.3.e109666.35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jamacardio.2021.0683","article-title":"Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease","volume":"6","author":"Lee","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026032607201885000_16.3.e109666.36","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/jgs.18172","article-title":"Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease","volume":"71","author":"Nanna","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"2026032607201885000_16.3.e109666.37","doi-asserted-by":"crossref","DOI":"10.1136\/heartasia-2018-011176","article-title":"Statin adherence and persistence on secondary prevention of cardiovascular disease in Taiwan","volume":"11","author":"Shau","year":"2019","journal-title":"Heart Asia"},{"key":"2026032607201885000_16.3.e109666.38","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cjco.2023.03.010","article-title":"Adherence to Cardiovascular Prevention Guidelines in an Academic Centre","volume":"5","author":"Soltani","year":"2023","journal-title":"CJC Open"},{"key":"2026032607201885000_16.3.e109666.39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.amjcard.2022.04.018","article-title":"Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events","volume":"176","author":"Tecson","year":"2022","journal-title":"Am J Cardiol"},{"key":"2026032607201885000_16.3.e109666.40","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejvs.2024.02.002","article-title":"Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study","volume":"67","author":"Thaarup","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026032607201885000_16.3.e109666.41","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25505","article-title":"Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016","volume":"3","author":"Yao","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026032607201885000_16.3.e109666.42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jacl.2020.11.004","article-title":"PCSK9 inhibition in clinical practice: Treatment patterns and attainment of lipid goals in a large health maintenance organization","volume":"15","author":"Zafrir","year":"2021","journal-title":"J Clin Lipidol"},{"key":"2026032607201885000_16.3.e109666.43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/19325037.2023.2254354","article-title":"Personal Health Literacy and Life Simple 7: The Multi-Ethnic Study of Atherosclerosis","volume":"54","author":"Adam","year":"2023","journal-title":"Am J Health Educ"},{"key":"2026032607201885000_16.3.e109666.44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4037\/ajcc2004.13.5.411","article-title":"Secondary prevention of hyperlipidemia after coronary artery bypass graft: from acute care to primary care","volume":"13","author":"Brackbill","year":"2004","journal-title":"Am J Crit Care"},{"key":"2026032607201885000_16.3.e109666.45","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1111\/ene.15850","article-title":"Long-term risk of recurrent vascular events and mortality in young stroke patients: Insights from a multicenter study","volume":"30","author":"Broman","year":"2023","journal-title":"Eur J Neurol"},{"key":"2026032607201885000_16.3.e109666.46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.amjcard.2022.06.016","article-title":"Health Literacy and Risk Factors for Coronary Artery Disease (From the CONCARDPCI Study)","volume":"179","author":"Br\u00f8rs","year":"2022","journal-title":"Am J Cardiol"},{"key":"2026032607201885000_16.3.e109666.47","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.22558","article-title":"Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China","volume":"7","author":"Chen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026032607201885000_16.3.e109666.48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000493530","article-title":"Medication Adherence of Statin Users after Acute Ischemic Stroke","volume":"80","author":"Chung","year":"2018","journal-title":"Eur Neurol"},{"key":"2026032607201885000_16.3.e109666.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.048"},{"key":"2026032607201885000_16.3.e109666.50","doi-asserted-by":"crossref","first-page":"105914","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105914","article-title":"Risk Factors Control and Early Recurrent Cerebral Infarction in Patients with Symptomatic Intracranial Atherosclerotic Disease","volume":"30","author":"Del Brutto","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026032607201885000_16.3.e109666.51","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jacc.2022.05.045","article-title":"Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial","volume":"80","author":"Garcia","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026032607201885000_16.3.e109666.52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/eurjpc\/zwaa104","article-title":"Offering, participation and adherence to cardiac rehabilitation programmes in the elderly: a European comparison based on the EU-CaRE multicentre observational study","volume":"28","author":"Gonz\u00e1lez-Salvado","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2026032607201885000_16.3.e109666.53","doi-asserted-by":"publisher","DOI":"10.1177\/2047487316632629"},{"key":"2026032607201885000_16.3.e109666.54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116513","article-title":"Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan","volume":"10","author":"Ho","year":"2015","journal-title":"PLoS One"},{"key":"2026032607201885000_16.3.e109666.55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1474515120940534","article-title":"Symptom experience as a predictor of cardiac rehabilitation education programme attendance after percutaneous coronary intervention: A prospective questionnaire survey","volume":"20","author":"Kim","year":"2021","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2026032607201885000_16.3.e109666.56","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s11845-022-03129-0","article-title":"Adherence to secondary prevention recommendations after coronary artery bypass graft surgery","volume":"192","author":"Keating","year":"2023","journal-title":"Ir J Med Sci"},{"key":"2026032607201885000_16.3.e109666.57","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/2047487312447751","article-title":"Persistence of uncontrolled cardiovascular risk factors in patients treated with percutaneous interventions for stable coronary artery disease not receiving cardiac rehabilitation","volume":"20","author":"Khattab","year":"2013","journal-title":"Eur J Prev Cardiolog"},{"key":"2026032607201885000_16.3.e109666.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2005.12.002"},{"key":"2026032607201885000_16.3.e109666.59","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.S133168"},{"key":"2026032607201885000_16.3.e109666.60","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.amjmed.2014.11.013","article-title":"Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease","volume":"128","author":"Kumbhani","year":"2015","journal-title":"Am J Med"},{"key":"2026032607201885000_16.3.e109666.61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amjmed.2012.02.025","article-title":"Predictors of adherence to performance measures in patients with acute myocardial infarction","volume":"126","author":"Kumbhani","year":"2013","journal-title":"Am J Med"},{"key":"2026032607201885000_16.3.e109666.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.01.033"},{"key":"2026032607201885000_16.3.e109666.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2008.09.014"},{"key":"2026032607201885000_16.3.e109666.64","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1097\/JCN.0000000000000830","article-title":"Patterns of Adherence to Secondary Prevention Measures Among Chinese Patients With Coronary Artery Disease: A Longitudinal Study","volume":"37","author":"Lu","year":"2022","journal-title":"J Cardiovasc Nurs"},{"key":"2026032607201885000_16.3.e109666.65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10557-021-07268-x","article-title":"The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg\/dL on the Number of Recurrent Events Among US Adults with ASCVD","volume":"37","author":"McKinley","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"2026032607201885000_16.3.e109666.66","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000035649.39669.CE"},{"key":"2026032607201885000_16.3.e109666.67","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/2047487312449593","article-title":"Are poor health behaviours in anxious and depressed cardiac patients explained by sociodemographic factors?","volume":"20","author":"Murphy","year":"2013","journal-title":"Eur J Prev Cardiolog"},{"key":"2026032607201885000_16.3.e109666.68","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCULATIONAHA.123.064440","article-title":"Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction","volume":"148","author":"Ohm","year":"2023","journal-title":"Circulation"},{"key":"2026032607201885000_16.3.e109666.69","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejvs.2018.09.023","article-title":"Adherence to Prescribed Drugs Among 65\u201374 Year Old Men Diagnosed with Abdominal Aortic Aneurysm or Peripheral Arterial Disease in a Screening Trial: A VIVA Substudy","volume":"57","author":"Qvist","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026032607201885000_16.3.e109666.70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jacl.2020.03.006","article-title":"Statin utilization and low-density lipoprotein cholesterol in statin-treated patients with atherosclerotic cardiovascular disease: Trends from a community-based health care delivery system, 2002\u20132016","volume":"14","author":"Romanelli","year":"2020","journal-title":"J Clin Lipidol"},{"key":"2026032607201885000_16.3.e109666.71","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.8.1081"},{"key":"2026032607201885000_16.3.e109666.72","doi-asserted-by":"crossref","DOI":"10.5334\/gh.1273","article-title":"Impact of Persistent Medication Adherence and Compliance with Lifestyle Recommendations on Major Cardiovascular Events and One-Year Mortality in Patients with Type 2 Diabetes and Advanced Stages of Atherosclerosis: Results From a Prospective Cohort Study","volume":"18","author":"Shalaeva","year":"2023","journal-title":"Glob Heart"},{"key":"2026032607201885000_16.3.e109666.73","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/2047487316687103","article-title":"Tenfold risk increase of major cardiovascular events after high limb amputation with non-compliance for secondary prevention measures","volume":"24","author":"Shalaeva","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"2026032607201885000_16.3.e109666.74","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/HCR.0b013e3181adcf0f","article-title":"Patterns and Predictors of Uptake and Adherence to Cardiac Rehabilitation","volume":"29","author":"Sharp","year":"2009","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"2026032607201885000_16.3.e109666.75","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jvs.2017.01.067","article-title":"Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study","volume":"66","author":"Sigvant","year":"2017","journal-title":"J Vasc Surg"},{"key":"2026032607201885000_16.3.e109666.76","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jvs.2017.05.115","article-title":"Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry","volume":"66","author":"Stavroulakis","year":"2017","journal-title":"J Vasc Surg"},{"key":"2026032607201885000_16.3.e109666.77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e125449","article-title":"Adherence to the 2018 American College of Cardiology and American Heart Association Guideline on the Management of Blood Cholesterol in ambulatory care settings: A cross-sectional study","volume":"71","author":"Tahaineh","year":"2024","journal-title":"PHAR"},{"key":"2026032607201885000_16.3.e109666.78","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.puhe.2016.02.003","article-title":"A comparison of secondary prevention practice in poststroke and coronary heart disease patients","volume":"137","author":"Van\u011bk","year":"2016","journal-title":"Public Health"},{"key":"2026032607201885000_16.3.e109666.79","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmr025"},{"key":"2026032607201885000_16.3.e109666.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcnurse.2009.11.002"},{"key":"2026032607201885000_16.3.e109666.81","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1590\/0004-282x20200027","article-title":"Effects of statin therapy on outcomes of ischemic stroke: a real-world experience in Brazil","volume":"78","author":"Vitturi","year":"2020","journal-title":"Arq Neuropsiquiatr"},{"key":"2026032607201885000_16.3.e109666.82","doi-asserted-by":"publisher","DOI":"10.1007\/S40266-019-00689-2"},{"key":"2026032607201885000_16.3.e109666.83","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s40266-020-00772-z","article-title":"Factors Associated with Reinitiation of Statin Treatment in Older Patients with Peripheral Arterial Disease","volume":"37","author":"Wawruch","year":"2020","journal-title":"Drugs Aging"},{"key":"2026032607201885000_16.3.e109666.84","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JCMA.0000000000000536","article-title":"Adherence to healthy lifestyle improved clinical outcomes in coronary artery disease patients after coronary intervention","volume":"84","author":"Yang","year":"2021","journal-title":"J Chin Med Assoc"},{"key":"2026032607201885000_16.3.e109666.85","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/j.jvs.2010.01.035","article-title":"Uninsured South Florida vascular surgery patients are less likely to receive optimal medical management than their insured counterparts","volume":"51","author":"Yeh","year":"2010","journal-title":"J Vasc Surg"},{"key":"2026032607201885000_16.3.e109666.86","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijcard.2016.05.003","article-title":"A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients\u2019 quality of life in Greece: The CHALLENGE study","volume":"217","author":"Alexopoulos","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026032607201885000_16.3.e109666.87","first-page":"332","article-title":"Medical risk factor treatment in peripheral arterial disease. Need for further improvement","volume":"32","author":"Alhadad","year":"2013","journal-title":"Int Angiol"},{"key":"2026032607201885000_16.3.e109666.88","doi-asserted-by":"publisher","DOI":"10.1177\/1741826711426090"},{"key":"2026032607201885000_16.3.e109666.89","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09593985.2019.1620388","article-title":"Barriers to participation in center-based cardiac rehabilitation programs and patients\u2019 attitude toward home-based cardiac rehabilitation programs","volume":"37","author":"Bakhshayeh","year":"2021","journal-title":"Physiother Theory Pract"},{"key":"2026032607201885000_16.3.e109666.90","doi-asserted-by":"crossref","DOI":"10.1186\/s13031-019-0217-x","article-title":"Cardiovascular Disease among Syrian refugees: a descriptive study of patients in two M\u00e9decins Sans Fronti\u00e8res clinics in northern Lebanon","volume":"13","author":"Boulle","year":"2019","journal-title":"Confl Health"},{"key":"2026032607201885000_16.3.e109666.91","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1734-1140(12)70778-8","article-title":"Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis \u2013 guidelines vs. reality","volume":"64","author":"Bo\u017centowicz-Wikarek","year":"2012","journal-title":"Pharmacol Rep"},{"key":"2026032607201885000_16.3.e109666.92","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011765","article-title":"Patient\u2010Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry","volume":"8","author":"Bradley","year":"2019","journal-title":"JAHA"},{"key":"2026032607201885000_16.3.e109666.93","doi-asserted-by":"crossref","first-page":"100665","DOI":"10.1016\/j.lanepe.2023.100665","article-title":"Optimal implementation of the 2019 ESC\/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study","volume":"31","author":"Brandts","year":"2023","journal-title":"The Lancet Regional Health - Europe"},{"key":"2026032607201885000_16.3.e109666.94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2004.11.010"},{"key":"2026032607201885000_16.3.e109666.95","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/09593985.2016.1229828","article-title":"Kinesiophobia mediates the influences on attendance at exercise-based cardiac rehabilitation in patients with coronary artery disease","volume":"32","author":"B\u00e4ck","year":"2016","journal-title":"Physiother Theory Pract"},{"key":"2026032607201885000_16.3.e109666.96","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0104-4230(12)70248-8","article-title":"Improving cardiovascular prevention through patient awareness","volume":"58","author":"Chang","year":"2012","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"2026032607201885000_16.3.e109666.97","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/VHRM.S106436","article-title":"Cardiovascular risk factor control is insufficient in young patients with coronary artery disease","volume":"12","author":"Christiansen","year":"2016","journal-title":"Vasc Health Risk Manag"},{"key":"2026032607201885000_16.3.e109666.98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1518-8345.6211.3879","article-title":"Factors that influence health literacy in patients with coronary artery disease","volume":"31","author":"Costa","year":"2023","journal-title":"Rev Latino-Am Enfermagem"},{"key":"2026032607201885000_16.3.e109666.99","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317549"},{"key":"2026032607201885000_16.3.e109666.100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.31674\/mjn.2023.v15isupp1.007","article-title":"Association between Sociodemographic Characteristics, Clinical Variables and Adherence Level on Lifestyle Modification among Patients with Coronary Artery Disease","volume":"15","author":"Esa","year":"2023","journal-title":"MJN"},{"key":"2026032607201885000_16.3.e109666.101","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.repc.2022.03.007","article-title":"Adherence to European guidelines for the use of aspirin in primary health care","volume":"42","author":"Ferreira Moita","year":"2023","journal-title":"Rev Port Cardiol"},{"key":"2026032607201885000_16.3.e109666.102","first-page":"5480","article-title":"The appropriateness of the use of statins for the secondary and primary prevention of atherosclerotic cardiovascular disease: a cross-sectional study from Jordan","volume":"27","author":"Gharaibeh","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026032607201885000_16.3.e109666.103","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1097\/HCR.0000000000000486","article-title":"Factors Associated With Attendance at a 1-yr Post\u2013Cardiac Rehabilitation Risk Factor Check","volume":"40","author":"Giannoccaro","year":"2020","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"2026032607201885000_16.3.e109666.104","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.688135"},{"key":"2026032607201885000_16.3.e109666.105","first-page":"552","article-title":"Medication Adherence In Post Myocardial Infarction Patients","volume":"30","author":"Hussain","year":"2018","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"2026032607201885000_16.3.e109666.106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5603\/CJ.a2014.0066","article-title":"Secondary prevention of coronary artery disease in contemporary clinical practice","volume":"22","author":"Jankowski","year":"2015","journal-title":"Cardiol J"},{"key":"2026032607201885000_16.3.e109666.107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-020-01635-2","article-title":"Factors influencing health behavior practice in patients with coronary artery diseases","volume":"19","author":"Jung","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"2026032607201885000_16.3.e109666.108","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.12142"},{"key":"2026032607201885000_16.3.e109666.109","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/2047487318781359","article-title":"Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey","volume":"25","author":"Kotseva","year":"2018","journal-title":"Eur J Prev Cardiolog"},{"key":"2026032607201885000_16.3.e109666.110","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1097\/NNR.0000000000000433","article-title":"Prediction of Changes in Adherence to Secondary Prevention Among Patients With Coronary Artery Disease","volume":"69","author":"Lu","year":"2020","journal-title":"Nurs Res"},{"key":"2026032607201885000_16.3.e109666.111","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.45964","article-title":"National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020","volume":"6","author":"Lu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026032607201885000_16.3.e109666.112","doi-asserted-by":"publisher","DOI":"10.1179\/174313208X300404"},{"key":"2026032607201885000_16.3.e109666.113","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11051","article-title":"Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease","volume":"3","author":"Mahtta","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026032607201885000_16.3.e109666.114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2010.01.026"},{"key":"2026032607201885000_16.3.e109666.115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ijcp.13358","article-title":"The reasons of poor lipid target attainment for secondary prevention in real life practice: Results from EPHESUS","volume":"73","author":"Mert","year":"2019","journal-title":"Int J Clin Pract"},{"key":"2026032607201885000_16.3.e109666.116","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-018-0896-z","article-title":"Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study","volume":"18","author":"Munkhaugen","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"2026032607201885000_16.3.e109666.117","doi-asserted-by":"publisher","DOI":"10.1177\/2047487317693134"},{"key":"2026032607201885000_16.3.e109666.118","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamacardio.2018.1511","article-title":"Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry","volume":"3","author":"Nanna","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026032607201885000_16.3.e109666.119","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005562","article-title":"Sex Differences in the Use of Statins in Community Practice","volume":"12","author":"Nanna","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026032607201885000_16.3.e109666.120","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8961690","article-title":"Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease","volume":"2018","author":"Ozkan","year":"2018","journal-title":"Biomed Res Int"},{"key":"2026032607201885000_16.3.e109666.121","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyp142"},{"key":"2026032607201885000_16.3.e109666.122","first-page":"21","article-title":"Educational needs: what female patients want from their cardiovascular health care providers","volume":"20","author":"Parks","year":"2011","journal-title":"Medsurg Nurs"},{"key":"2026032607201885000_16.3.e109666.123","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jacl.2018.11.004","article-title":"Higher long-term adherence to statins in rural patients at high atherosclerotic risk","volume":"13","author":"Peverelle","year":"2019","journal-title":"J Clin Lipidol"},{"key":"2026032607201885000_16.3.e109666.124","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1111\/jocn.16656","article-title":"Patient\u2019s learning needs and self-efficacy level after percutaneous coronary intervention: A descriptive study","volume":"32","author":"Salgado","year":"2023","journal-title":"J Clin Nurs"},{"key":"2026032607201885000_16.3.e109666.125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5334\/gh.932","article-title":"Ambulatory Patients with Cardiometabolic Disease and Without Evidence of COVID-19 During the Pandemic. The CorCOVID LATAM Study","volume":"16","author":"Lopez Santi","year":"2021","journal-title":"gh"},{"key":"2026032607201885000_16.3.e109666.126","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1358863X231181613","article-title":"Patient knowledge and preferences for peripheral artery disease treatment","volume":"28","author":"Smolderen","year":"2023","journal-title":"Vasc Med"},{"key":"2026032607201885000_16.3.e109666.127","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jvn.2022.09.001","article-title":"Health literacy in patients with intermittent claudication in relation to clinical characteristics, demographics, self-efficacy and quality of life - A cross-sectional study","volume":"40","author":"Striberger","year":"2022","journal-title":"J Vasc Nurs"},{"key":"2026032607201885000_16.3.e109666.128","first-page":"260","article-title":"Knowledge, Attitude, and Practice Regarding Cardiovascular Disease among Coronary Artery Disease and Premature Coronary Artery Disease Patients Referred to Imam Hossein Hospital, Tehran, Iran","volume":"18","author":"Vahedi","year":"2023","journal-title":"JTHC"},{"key":"2026032607201885000_16.3.e109666.129","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035839","article-title":"Combined effect of left ventricular ejection fraction and obesity on sedentary behavior in patients with coronary artery disease","volume":"102","author":"Won","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"2026032607201885000_16.3.e109666.130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jval.2018.08.006","article-title":"Methods for Measuring Multiple Medication Adherence: A Systematic Review-Report of the ISPOR Medication Adherence and Persistence Special Interest Group","volume":"22","author":"Pednekar","year":"2019","journal-title":"Value Health"},{"key":"2026032607201885000_16.3.e109666.131","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-022-01199-7"},{"key":"2026032607201885000_16.3.e109666.132","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/hea0001441","article-title":"Sex and gender disparities in health behaviors and adherence in patients recovering from percutaneous coronary intervention","volume":"44","author":"van den Houdt","year":"2024","journal-title":"Health Psychol"},{"key":"2026032607201885000_16.3.e109666.133","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.3390\/ijerph18041700","article-title":"Gender Differences in Uptake, Adherence and Experiences: A Longitudinal, Mixed-Methods Study of a Physical Activity Referral Scheme in Scotland, UK","volume":"18","author":"Hanson","year":"2021","journal-title":"IJERPH"},{"key":"2026032607201885000_16.3.e109666.134","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.51156","article-title":"Trends in Provision of Medications and Lifestyle Counseling in Ambulatory Settings by Gender and Race for Patients With Atherosclerotic Cardiovascular Disease, 2006-2016","volume":"6","author":"Mufarreh","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026032607201885000_16.3.e109666.135","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jvs.2022.12.015","article-title":"The global burden of peripheral artery disease","volume":"77","author":"Eid","year":"2023","journal-title":"J Vasc Surg"},{"key":"2026032607201885000_16.3.e109666.136","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.108787"},{"key":"2026032607201885000_16.3.e109666.137","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2008.07572.x"},{"key":"2026032607201885000_16.3.e109666.138","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/eurheartj\/ehae867","article-title":"Lifetime risk of lower extremity peripheral arterial disease: a Danish nationwide longitudinal study","volume":"46","author":"S\u00f8gaard","year":"2025","journal-title":"Eur Heart J"},{"key":"2026032607201885000_16.3.e109666.139","doi-asserted-by":"crossref","unstructured":"S\u00f8gaard M , Skj\u00f8th F , Behrendt C-A , et al . Adherence to Antithrombotic and Lipid Lowering Therapy and Clinical Outcomes in Patients with Lower Extremity Peripheral Arterial Disease: A Nationwide Nested Case Control Study. Eur J Vasc Endovasc Surg 2025. doi:10.1016\/j.ejvs.2025.09.015","DOI":"10.1016\/j.ejvs.2025.09.015"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-109666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:21:09Z","timestamp":1774534869000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-109666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":139,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,26]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjopen-2025-109666"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-109666","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}